# Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer

> **NCT07468838** · — · NOT_YET_RECRUITING · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 25 (estimated)

## Conditions studied

- Prostate Cancer
- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07468838
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07468838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07468838, "Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07468838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*